{"id":"azacitidine-associated-with-lenalidomide","safety":{"commonSideEffects":[{"rate":"34%","effect":"Fatigue"},{"rate":"31%","effect":"Nausea"},{"rate":"28%","effect":"Diarrhea"},{"rate":"26%","effect":"Cough"},{"rate":"25%","effect":"Pyrexia"}]},"_chembl":{"chemblId":"CHEMBL848","moleculeType":"Small molecule","molecularWeight":"259.26"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Azacitidine works by inhibiting DNA methyltransferase enzymes, leading to hypomethylation of DNA and subsequent reactivation of silenced genes. This mechanism is thought to contribute to its therapeutic effects in myelodysplastic syndromes and acute myeloid leukemia.","oneSentence":"Azacitidine is a DNA methyltransferase inhibitor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:30:13.698Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Myelodysplastic syndromes"},{"name":"Acute myeloid leukemia"}]},"trialDetails":[{"nctId":"NCT01342692","phase":"PHASE2","title":"Best Promising Drug Association With Azacitidine in Higher Risk Myelodysplastic Syndromes","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2011-06","conditions":"MDS","enrollment":320}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Azacitidine associated with Lenalidomide","genericName":"Azacitidine associated with Lenalidomide","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Azacitidine is a DNA methyltransferase inhibitor. Used for Myelodysplastic syndromes, Acute myeloid leukemia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}